Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	zinc ion binding	TET2 SEMG2 HIVEP1 CIZ1 ERVK-5 ZMYM2 ERVK-19 RORC ERVK-21 TRIM24 CREBBP ESCO1 TAB3	2.13e-05	891	74	13	GO:0008270
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	MED15 TSC22D1 MAK YAF2 BAZ2A TNRC6A STRN4 BLNK CCAR1 YY1AP1 TRIM24 CREBBP CAPRIN1 WNK3	7.93e-05	1160	74	14	GO:0030674
GeneOntologyMolecularFunction	molecular adaptor activity	MED15 TSC22D1 MAK YAF2 BAZ2A TNRC6A STRN4 BLNK CCAR1 YY1AP1 TRIM24 CREBBP CAPRIN1 WNK3 TAB3	1.13e-04	1356	74	15	GO:0060090
GeneOntologyMolecularFunction	transition metal ion binding	TET2 SEMG2 HIVEP1 CIZ1 ERVK-5 ZMYM2 ERVK-19 RORC ERVK-21 TRIM24 CREBBP ESCO1 TAB3	3.88e-04	1189	74	13	GO:0046914
GeneOntologyMolecularFunction	molecular condensate scaffold activity	BLNK CAPRIN1 WNK3	5.06e-04	42	74	3	GO:0140693
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	BPTF SP2 GTF2A1 SP4 HIVEP1 ZBTB33 NFYC CCAR1 RORC ATF4 RFX7 TRIM24 CREBBP CREB5	8.34e-04	1459	74	14	GO:0000977
GeneOntologyMolecularFunction	cAMP response element binding protein binding	ATF4 CREBBP	8.73e-04	12	74	2	GO:0008140
GeneOntologyMolecularFunction	transcription coactivator activity	TSC22D1 MAK YAF2 CCAR1 TRIM24 CREBBP	9.06e-04	303	74	6	GO:0003713
GeneOntologyMolecularFunction	transcription coregulator activity	MED15 TSC22D1 MAK YAF2 CCAR1 YY1AP1 TRIM24 CREBBP	1.10e-03	562	74	8	GO:0003712
GeneOntologyMolecularFunction	core promoter sequence-specific DNA binding	GTF2A1 BAZ2A RFX7	1.12e-03	55	74	3	GO:0001046
GeneOntologyMolecularFunction	general transcription initiation factor binding	GTF2A1 ATF4 CREBBP	1.73e-03	64	74	3	GO:0140296
GeneOntologyMolecularFunction	transcription factor binding	BPTF GTF2A1 BAZ2A ARID2 LRP2 RORC ATF4 TRIM24 CREBBP	1.82e-03	753	74	9	GO:0008134
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	BPTF SP2 SP4 HIVEP1 ZBTB33 NFYC CCAR1 RORC ATF4 RFX7 TRIM24 CREB5	1.96e-03	1244	74	12	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	BPTF SP2 SP4 HIVEP1 ZBTB33 NFYC CCAR1 RORC ATF4 RFX7 TRIM24 CREB5	2.34e-03	1271	74	12	GO:0000987
GeneOntologyCellularComponent	nuclear protein-containing complex	MED15 BPTF GTF2A1 EP400 BAZ2A ARID2 NFYC SUGP1 AFF1 POM121L2 YY1AP1 ATF4 NUP214 CREBBP CCNK PHF21A	1.69e-05	1377	73	16	GO:0140513
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	BPTF EP400 BAZ2A ARID2 YY1AP1	2.16e-05	96	73	5	GO:0070603
GeneOntologyCellularComponent	chromatin	BPTF SP2 SP4 ZBTB33 EP400 BAZ2A ARID2 NFYC YY1AP1 RORC ATF4 RFX7 TRIM24 CREBBP ESCO1 CREB5	4.09e-05	1480	73	16	GO:0000785
GeneOntologyCellularComponent	ATPase complex	BPTF EP400 BAZ2A ARID2 YY1AP1	8.89e-05	129	73	5	GO:1904949
GeneOntologyCellularComponent	nuclear body	HIVEP1 EP400 RAPH1 SUGP2 BAZ2A OBSCN ZMYM2 YY1AP1 RORC ATF4 CREBBP	2.82e-04	903	73	11	GO:0016604
GeneOntologyCellularComponent	ISWI-type complex	BPTF BAZ2A	1.07e-03	14	73	2	GO:0031010
HumanPheno	Broad nasal tip	BPTF PTPRF ARID2 LRP2 ZMYM2 QRICH1 RFX7 CCNK CAPRIN1 PHF21A	5.36e-09	159	28	10	HP:0000455
HumanPheno	Abnormal nasal tip morphology	BPTF PTPRF ARID2 LRP2 ZMYM2 QRICH1 RFX7 MBD5 CCNK CAPRIN1 PHF21A	2.71e-06	386	28	11	HP:0000436
HumanPheno	Clinodactyly	BPTF ARID2 ZMYM2 YY1AP1 QRICH1 RFX7 MBD5 CREBBP CCNK CAPRIN1 WNK3 PHF21A	2.07e-05	574	28	12	HP:0030084
HumanPheno	Anteverted nares	BPTF PTPRF ARID2 LRP2 ZMYM2 QRICH1 RFX7 CREBBP CCNK CAPRIN1 PHF21A	9.41e-05	559	28	11	HP:0000463
HumanPheno	Upturned nose	BPTF PTPRF ARID2 LRP2 ZMYM2 QRICH1 RFX7 CREBBP CCNK CAPRIN1 PHF21A	9.41e-05	559	28	11	HP:0000427
HumanPheno	Abnormal nostril morphology	BPTF PTPRF ARID2 LRP2 ZMYM2 QRICH1 RFX7 CREBBP CCNK CAPRIN1 PHF21A	1.22e-04	575	28	11	HP:0005288
Domain	Bromodomain_CS	BPTF BAZ2A TRIM24 CREBBP	2.54e-06	26	70	4	IPR018359
Domain	BROMODOMAIN_1	BPTF BAZ2A TRIM24 CREBBP	1.09e-05	37	70	4	PS00633
Domain	Bromodomain	BPTF BAZ2A TRIM24 CREBBP	1.21e-05	38	70	4	PF00439
Domain	BROMODOMAIN_2	BPTF BAZ2A TRIM24 CREBBP	1.65e-05	41	70	4	PS50014
Domain	BROMO	BPTF BAZ2A TRIM24 CREBBP	1.82e-05	42	70	4	SM00297
Domain	Bromodomain	BPTF BAZ2A TRIM24 CREBBP	1.82e-05	42	70	4	IPR001487
Domain	-	BPTF BAZ2A TRIM24 CREBBP	1.82e-05	42	70	4	1.20.920.10
Domain	TSC-22_Dip_Bun	TSC22D1 TSC22D2	8.27e-05	4	70	2	IPR000580
Domain	TSC22	TSC22D1 TSC22D2	8.27e-05	4	70	2	PF01166
Domain	TSC-22_Dip_Bun	TSC22D1 TSC22D2	8.27e-05	4	70	2	PD007152
Domain	DDT	BPTF BAZ2A	8.27e-05	4	70	2	PF02791
Domain	TSC22	TSC22D1 TSC22D2	8.27e-05	4	70	2	PS01289
Domain	DDT	BPTF BAZ2A	1.37e-04	5	70	2	SM00571
Domain	WSD	BPTF BAZ2A	1.37e-04	5	70	2	PF15613
Domain	WHIM1	BPTF BAZ2A	1.37e-04	5	70	2	PF15612
Domain	DUF3504	ZMYM2 QRICH1	1.37e-04	5	70	2	IPR021893
Domain	DUF3504	ZMYM2 QRICH1	1.37e-04	5	70	2	PF12012
Domain	DDT_dom	BPTF BAZ2A	1.37e-04	5	70	2	IPR018501
Domain	WHIM1_dom	BPTF BAZ2A	1.37e-04	5	70	2	IPR028942
Domain	WHIM2_dom	BPTF BAZ2A	1.37e-04	5	70	2	IPR028941
Domain	PHD	BPTF BAZ2A TRIM24 PHF21A	1.80e-04	75	70	4	PF00628
Domain	DDT	BPTF BAZ2A	2.06e-04	6	70	2	PS50827
Domain	Surp	SUGP2 SUGP1	2.06e-04	6	70	2	PF01805
Domain	SWAP	SUGP2 SUGP1	2.06e-04	6	70	2	SM00648
Domain	SURP	SUGP2 SUGP1	2.06e-04	6	70	2	PS50128
Domain	Surp	SUGP2 SUGP1	2.06e-04	6	70	2	IPR000061
Domain	Znf_PHD-finger	BPTF BAZ2A TRIM24 PHF21A	2.20e-04	79	70	4	IPR019787
Domain	PHD	BPTF BAZ2A TRIM24 PHF21A	3.47e-04	89	70	4	SM00249
Domain	Znf_PHD	BPTF BAZ2A TRIM24 PHF21A	3.78e-04	91	70	4	IPR001965
Domain	ZF_PHD_2	BPTF BAZ2A TRIM24 PHF21A	4.45e-04	95	70	4	PS50016
Domain	ZF_PHD_1	BPTF BAZ2A TRIM24 PHF21A	4.64e-04	96	70	4	PS01359
Domain	RFX_DNA_binding	ARID2 RFX7	4.90e-04	9	70	2	PF02257
Domain	DNA-bd_RFX	ARID2 RFX7	4.90e-04	9	70	2	IPR003150
Domain	RFX_DBD	ARID2 RFX7	4.90e-04	9	70	2	PS51526
Domain	Sp1_fam	SP2 SP4	6.11e-04	10	70	2	IPR030450
Domain	Methyl_CpG_DNA-bd	BAZ2A MBD5	7.45e-04	11	70	2	IPR001739
Domain	MBD	BAZ2A MBD5	7.45e-04	11	70	2	PF01429
Domain	DNA-bd_dom	BAZ2A MBD5	7.45e-04	11	70	2	IPR016177
Domain	MBD	BAZ2A MBD5	7.45e-04	11	70	2	SM00391
Domain	MBD	BAZ2A MBD5	7.45e-04	11	70	2	PS50982
Domain	AT_hook	BAZ2A PHF21A	1.61e-03	16	70	2	PF02178
Domain	Zinc_finger_PHD-type_CS	BPTF TRIM24 PHF21A	1.86e-03	65	70	3	IPR019786
Domain	Znf_FYVE_PHD	BPTF BAZ2A TRIM24 PHF21A	2.26e-03	147	70	4	IPR011011
Domain	zf-RanBP	YAF2 TAB3	3.05e-03	22	70	2	PF00641
Domain	G_patch	SUGP2 SUGP1	3.33e-03	23	70	2	SM00443
Domain	G_patch_dom	SUGP2 SUGP1	3.33e-03	23	70	2	IPR000467
Domain	ZnF_RBZ	YAF2 TAB3	3.33e-03	23	70	2	SM00547
Domain	G_PATCH	SUGP2 SUGP1	3.33e-03	23	70	2	PS50174
Domain	ZF_RANBP2_2	YAF2 TAB3	3.33e-03	23	70	2	PS50199
Domain	G-patch	SUGP2 SUGP1	3.33e-03	23	70	2	PF01585
Domain	ZF_RANBP2_1	YAF2 TAB3	3.62e-03	24	70	2	PS01358
Domain	Znf_RanBP2	YAF2 TAB3	3.93e-03	25	70	2	IPR001876
Domain	AT_hook	BAZ2A PHF21A	4.57e-03	27	70	2	SM00384
Domain	AT_hook_DNA-bd_motif	BAZ2A PHF21A	4.57e-03	27	70	2	IPR017956
Domain	HMGI/Y_DNA-bd_CS	BAZ2A PHF21A	6.00e-03	31	70	2	IPR000637
Domain	bZIP_1	ATF4 CREB5	7.19e-03	34	70	2	PF00170
Pathway	KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION	ATF4 CREBBP CREB5	1.65e-05	13	56	3	M47595
Pubmed	Human transcription factor protein interaction networks.	MED15 TET2 BPTF SP2 HIVEP1 ZBTB33 YAF2 FAM120A EP400 SUGP2 PRRC2C ARID2 ZBTB21 TNRC6A NFYC SUGP1 LRP2 CCAR1 ZMYM2 YY1AP1 NUP214 RFX7 TRIM24 CREBBP CAPRIN1 EMSY PHF21A TAB3	3.76e-20	1429	74	28	35140242
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	MED15 TET2 BPTF SP4 HIVEP1 FAM120A EP400 SUGP2 PRRC2C ARID2 ZBTB21 SUGP1 CCAR1 ZMYM2 QRICH1 TRIM24 CREBBP CCNK CAPRIN1 ZYX EMSY PHF21A	6.60e-16	1103	74	22	34189442
Pubmed	A human MAP kinase interactome.	PARD6B GTF2A1 TSC22D1 HIVEP1 EXPH5 ARID2 TNRC6A NFYC NAV2 ZMYM2 YY1AP1 ATF4 NUP214 MBD5 CREBBP ZYX	5.29e-15	486	74	16	20936779
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	MED15 TET2 HIVEP1 ZBTB33 EP400 ZBTB21 SUGP1 ZMYM2 TRIM24 CREBBP CCNK EMSY PHF21A	1.74e-14	268	74	13	33640491
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	MED15 SP2 ZBTB33 EP400 ZBTB21 AAK1 SUGP1 ZMYM2 QRICH1 TRIM24 CREBBP CAPRIN1 ZYX EMSY PHF21A	2.83e-14	444	74	15	34795231
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	MED15 BPTF ZBTB33 EP400 RAPH1 SUGP2 BAZ2A PRRC2C ARID2 CIZ1 STRN4 CREBBP CCNK ZYX EMSY TAB3	3.46e-14	549	74	16	38280479
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	BPTF SP2 GTF2A1 SP4 TSC22D1 HIVEP1 ZBTB33 BAZ2A ARID2 ZBTB21 CIZ1 NFYC CCAR1 ZMYM2 ATF4 TRIM24 ZYX PHF21A	6.94e-14	808	74	18	20412781
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	BPTF HIVEP1 EP400 RAPH1 SUGP2 BAZ2A ZBTB21 AAK1 CCAR1 ZMYM2 AFF1 YY1AP1 NUP214 RFX7 CCNK ZYX EMSY	4.76e-13	774	74	17	15302935
Pubmed	Interaction network of human early embryonic transcription factors.	MED15 TET2 BPTF HIVEP1 EP400 ARID2 ZMYM2 NUP214 RFX7 TRIM24 CREBBP EMSY PHF21A	5.43e-13	351	74	13	38297188
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GTF2A1 ZBTB33 EP400 RAPH1 SUGP2 BAZ2A PRRC2C ARID2 ZBTB21 AAK1 CIZ1 SUGP1 ZMYM2 NUP214 CCNK ZYX EMSY PHF21A	7.95e-13	934	74	18	33916271
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	MED15 TET2 GTF2A1 TNRC6A CIZ1 RFX7 CREBBP CCNK TAB3	3.97e-11	152	74	9	38360978
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	MED15 TET2 SP2 HIVEP1 EP400 ARID2 CIZ1 NFYC YY1AP1 TRIM24 CREBBP PHF21A	4.96e-11	398	74	12	35016035
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	BPTF HIVEP1 ZBTB33 EP400 SUGP2 BAZ2A PRRC2C ARID2 CIZ1 SUGP1 CCAR1 ZMYM2 NUP214 TRIM24 CCNK EMSY	1.38e-10	954	74	16	36373674
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	BPTF ZBTB33 FAM120A EP400 SUGP2 PRRC2C ZBTB21 NFYC ZMYM2 QRICH1 TRIM24 CREBBP CREB5 EMSY PHF21A	3.14e-10	857	74	15	25609649
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TET2 HIVEP1 ZBTB33 RAPH1 ZBTB21 TNRC6A LRP2 ZMYM2 NUP214 TRIM24 PHF21A	1.41e-09	418	74	11	34709266
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	GTF2A1 EP400 SUGP2 SUGP1 ZMYM2 YY1AP1 TRIM24 CCNK EMSY PHF21A	2.80e-09	339	74	10	30415952
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	BPTF GTF2A1 ZBTB33 EP400 SUGP2 BAZ2A SUGP1 CCNK EMSY	9.59e-09	283	74	9	30585729
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CACNA1A FAM120A WDR7 PRRC2C ZBTB21 AAK1 STRN4 CCAR1 ZMYM2 LRRC7 CTNND2 CAPRIN1 EMSY WNK3	1.38e-08	963	74	14	28671696
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TET2 HIVEP1 RAPH1 EXPH5 PRRC2C STARD9 ZBTB21 AAK1 NAV2 RFX7 ZYX WNK3 TAB3	3.12e-08	861	74	13	36931259
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	BPTF ZBTB33 FAM120A EP400 SUGP2 BAZ2A ARID2 ZBTB21 TNRC6A CIZ1 LRP2 TRIM24 CREBBP PHF21A	8.58e-08	1116	74	14	31753913
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	AFMID TET2 BPTF GTF2A1 SUGP2 ARID2 TNRC6A QRICH1 MBD5 PHF21A	2.07e-07	536	74	10	15840001
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	EP400 SUGP2 WDR7 BAZ2A PRRC2C STARD9 YY1AP1 LRRC7 NUP214	2.13e-07	407	74	9	12693553
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	AFMID TET2 BPTF GTF2A1 SUGP2 ARID2 TNRC6A QRICH1 MBD5 PHF21A	2.14e-07	538	74	10	10512203
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SP2 GTF2A1 HIVEP1 ZBTB33 BAZ2A RORC ATF4 QRICH1 CREBBP ZYX PHF21A	3.05e-07	709	74	11	22988430
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	ZBTB33 EP400 SUGP1 ZMYM2 TRIM24 CCNK	4.37e-07	134	74	6	25452129
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	AFMID BPTF TSC22D1 FAM120A SUGP2 WASF3 AAK1 OBSCN BLNK CCAR1 AFF1 LRRC7 MBD5 CREBBP ESCO1	4.68e-07	1489	74	15	28611215
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	EP400 ZBTB21 SUGP1 ZMYM2 TRIM24 CREBBP EMSY	4.92e-07	222	74	7	37071664
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	BPTF BAZ2A TRIM24 CREBBP EMSY	5.84e-07	75	74	5	25593309
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	BPTF YAF2 EP400 BAZ2A ARID2 CREBBP	1.11e-06	157	74	6	30186101
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	MED15 SUGP2 KIAA0319L TNRC6A CCAR1 RFX7	2.45e-06	180	74	6	35198878
Pubmed	Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2.	ARID2 ZMYM2 TSC22D2 WNK3	2.63e-06	45	74	4	27337956
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	BPTF ZBTB33 EP400 SUGP2 BAZ2A ZBTB21 CCAR1 ZMYM2	2.71e-06	411	74	8	35182466
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MED15 PARD6B EP400 BAZ2A ARID2 TNRC6A AAK1 CIZ1 STRN4 CCAR1 ZMYM2 CTNND2 CCNK EMSY	2.85e-06	1497	74	14	31527615
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	BPTF SP2 YAF2 EP400 BAZ2A CIZ1 CCAR1 ZMYM2 NUP214 RFX7 ESCO1 EMSY PHF21A	3.13e-06	1294	74	13	30804502
Pubmed	A census of human transcription factors: function, expression and evolution.	SP2 SP4 TSC22D1 HIVEP1 ZBTB33 NFYC RORC ATF4 TSC22D2 RFX7 CREB5	3.37e-06	908	74	11	19274049
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	HIVEP1 EP400 PRRC2C ARID2 TNRC6A ZMYM2 YY1AP1 CREBBP EMSY	4.42e-06	588	74	9	38580884
Pubmed	Expression of human gene coding RORγT receptor depends on the Sp2 transcription factor.	SP2 RORC	4.47e-06	2	74	2	27256574
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	BPTF HIVEP1 BAZ2A ARID2 ZBTB21 CIZ1 ZMYM2 TRIM24 EMSY	5.78e-06	608	74	9	36089195
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	BPTF FAM120A EP400 PRRC2C TNRC6A CCAR1 NUP214 CCNK	7.13e-06	469	74	8	27634302
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	BPTF GTF2A1 EP400 RAPH1 SUGP2 ARID2 CCNK CAPRIN1	7.47e-06	472	74	8	38943005
Pubmed	Tagging genes with cassette-exchange sites.	BPTF WDR7 PRRC2C NAV2 QRICH1 RFX7 CREBBP	7.48e-06	335	74	7	15741177
Pubmed	PRC1 and PRC2 are not required for targeting of H2A.Z to developmental genes in embryonic stem cells.	MED15 EP400 EMSY PHF21A	1.16e-05	65	74	4	22496869
Pubmed	Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors.	PARD6B BPTF WDR7 ARID2 CCAR1 CREBBP CAPRIN1	1.17e-05	359	74	7	35559673
Pubmed	Regulation of transcription factor C/ATF by the cAMP signal activation in hippocampal neurons, and molecular interaction of C/ATF with signal integrator CBP/p300.	ATF4 CREBBP	1.34e-05	3	74	2	10350644
Pubmed	Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300.	EP400 CREBBP	1.34e-05	3	74	2	9590171
Pubmed	Madm (Mlf1 adapter molecule) cooperates with Bunched A to promote growth in Drosophila.	TSC22D1 TSC22D2	1.34e-05	3	74	2	20149264
Pubmed	SF4 and SFRS14, two related putative splicing factors on human chromosome 19p13.11.	SUGP2 SUGP1	1.34e-05	3	74	2	12594045
Pubmed	DNA hypermethylation is associated with invasive phenotype of malignant melanoma.	TET2 NAV2	1.34e-05	3	74	2	31602702
Pubmed	Upregulation of δ-catenin is associated with poor prognosis and enhances transcriptional activity through Kaiso in non-small-cell lung cancer.	ZBTB33 CTNND2	1.34e-05	3	74	2	21070476
Pubmed	O-GlcNAc modification of Sp3 and Sp4 transcription factors negatively regulates their transcriptional activities.	SP2 SP4	1.34e-05	3	74	2	26431879
Pubmed	Densin-180 interacts with delta-catenin/neural plakophilin-related armadillo repeat protein at synapses.	LRRC7 CTNND2	1.34e-05	3	74	2	11729199
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	MED15 BPTF SP2 ZBTB33 AAK1 SUGP1 NUP214	1.42e-05	370	74	7	22922362
Pubmed	cDNAs with long CAG trinucleotide repeats from human brain.	MED15 EP400 TNRC6A	1.59e-05	23	74	3	9225980
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	BPTF FAM120A PRRC2C SUGP1 CCAR1 CCNK	1.64e-05	251	74	6	31076518
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	BPTF EP400 BAZ2A ZMYM2 PHF21A	1.77e-05	150	74	5	28242625
Pubmed	NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.	TET2 BPTF EMSY	2.61e-05	27	74	3	23395962
Pubmed	Laser capture microdissection and cDNA array analysis for identification of mouse KIAA/FLJ genes differentially expressed in the embryonic dorsal spinal cord.	BAZ2A NAV2 NUP214	2.61e-05	27	74	3	19026994
Pubmed	QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis.	ATF4 QRICH1	2.67e-05	4	74	2	33384352
Pubmed	Regulation of the rapsyn promoter by kaiso and delta-catenin.	ZBTB33 CTNND2	2.67e-05	4	74	2	15282317
Pubmed	Sustained ER stress promotes hyperglycemia by increasing glucagon action through the deubiquitinating enzyme USP14.	ATF4 CREBBP	2.67e-05	4	74	2	31594848
Pubmed	Regulation of expression of the chorionic gonadotropin/luteinizing hormone receptor gene in the human myometrium: involvement of specificity protein-1 (Sp1), Sp3, Sp4, Sp-like proteins, and histone deacetylases.	SP2 SP4	2.67e-05	4	74	2	15788387
Pubmed	Binding and modulation of p53 by p300/CBP coactivators.	EP400 CREBBP	2.67e-05	4	74	2	9194565
Pubmed	Interactions of Rabconnectin-3 with Cav2 calcium channels.	CACNA1A WDR7	2.67e-05	4	74	2	31253182
Pubmed	Sp2 is the only glutamine-rich specificity protein with minor impact on development and differentiation in myelinating glia.	SP2 SP4	2.67e-05	4	74	2	27889927
Pubmed	Prostaglandin E2 signalling pathway in human T lymphocytes from healthy and conjunctiva basal cell carcinoma-bearing subjects.	ATF4 CREBBP	2.67e-05	4	74	2	11564156
Pubmed	p300 modulates ATF4 stability and transcriptional activity independently of its acetyltransferase domain.	ATF4 CREBBP	2.67e-05	4	74	2	16219772
Pubmed	Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.	ERVK-5 ERVK-19	2.67e-05	4	74	2	7983737
Pubmed	Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24.	TRIM24 CREBBP	2.67e-05	4	74	2	31554795
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	MED15 BPTF EP400 ZMYM2 EMSY	2.96e-05	167	74	5	20362541
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	BPTF EP400 ZMYM2 TRIM24	3.05e-05	83	74	4	28794006
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	PARD6B FAM120A EP400 SUGP2 PRRC2C STARD9 TNRC6A AAK1 CCAR1 CCNK CAPRIN1 ITIH2	3.07e-05	1371	74	12	36244648
Pubmed	Functional proteomics mapping of a human signaling pathway.	HIVEP1 PTPRF EXPH5 ZMYM2 AFF1 QRICH1 CREBBP ZYX	3.73e-05	591	74	8	15231748
Pubmed	A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.	SEMG2 BAZ2A NFYC AFF1 NUP214 RFX7 EMSY	3.76e-05	431	74	7	33660365
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-19 ERVK-21	4.45e-05	5	74	2	12629516
Pubmed	Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.	SP2 SP4	4.45e-05	5	74	2	10547281
Pubmed	Characterization of human activating transcription factor 4, a transcriptional activator that interacts with multiple domains of cAMP-responsive element-binding protein (CREB)-binding protein.	ATF4 CREBBP	4.45e-05	5	74	2	9295363
Pubmed	Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain.	TRIM24 CREBBP	4.45e-05	5	74	2	11931765
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	MED15 HIVEP1 SUGP2 LRP2 YY1AP1 QRICH1 CCNK ZYX	4.56e-05	608	74	8	16713569
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	MED15 PRRC2C TNRC6A NUP214 QRICH1 TRIM24 CREBBP	5.45e-05	457	74	7	32344865
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	FAM120A SUGP2 PRRC2C TNRC6A NUP214 CAPRIN1 WNK3	5.83e-05	462	74	7	31138677
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	MED15 HIVEP1 ARID2 SUGP1 ZMYM2 CTNND2 TRIM24 CREBBP	6.38e-05	638	74	8	31182584
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	TET2 ARID2 OBSCN WNK3	6.59e-05	101	74	4	10997877
Pubmed	Transcriptional regulation of P450scc gene expression in the embryonic rodent nervous system.	SP2 SP4	6.66e-05	6	74	2	14576192
Pubmed	A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.	TRIM24 CREBBP	6.66e-05	6	74	2	10610177
Pubmed	Nkx3.1 binds and negatively regulates the transcriptional activity of Sp-family members in prostate-derived cells.	SP2 SP4	6.66e-05	6	74	2	16201967
Pubmed	Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo.	BPTF RAPH1 KIAA0319L NFYC NAV2 AFF1	7.02e-05	326	74	6	17015433
Pubmed	ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease.	TSC22D1 WDR7 WASF3 AAK1 CAPRIN1	7.32e-05	202	74	5	33601422
Pubmed	Linking functions: an additional role for an intrinsically disordered linker domain in the transcriptional coactivator CBP.	PTPRF ZMYM2 CREBBP	7.39e-05	38	74	3	28680062
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	BPTF FAM120A SUGP2 BAZ2A PRRC2C CCAR1 NUP214 CAPRIN1	7.50e-05	653	74	8	22586326
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	BPTF ZBTB33 EP400 ARID2 ZMYM2 NUP214	7.76e-05	332	74	6	32786267
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TET2 FAM120A KIAA0319L LRP2 CCAR1 ZMYM2 YY1AP1 QRICH1 CTNND2 CREBBP CAPRIN1	8.30e-05	1285	74	11	35914814
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SP2 TSC22D1 FAM120A EXPH5 ARID2 MBD5 ESCO1	8.74e-05	493	74	7	15368895
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	BPTF EP400 BAZ2A ZMYM2 YY1AP1 EMSY	8.99e-05	341	74	6	32971831
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	CACNA1A WDR7 AAK1 STRN4 LRRC7 CTNND2	9.89e-05	347	74	6	17114649
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	ZBTB33 RAPH1 PRRC2C AAK1 ZYX	1.00e-04	216	74	5	31519766
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	SP2 GTF2A1 ZBTB33 SUGP2 ZMYM2 RORC ATF4 TRIM24 CREBBP	1.01e-04	877	74	9	20211142
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	ZBTB33 FAM120A SUGP2 BAZ2A ZMYM2 CAPRIN1	1.02e-04	349	74	6	25665578
Pubmed	Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags.	MED15 TSC22D1 SUGP2 PRRC2C CCAR1 RORC ITIH2	1.08e-04	510	74	7	16712791
Pubmed	USP7 Regulates Cytokinesis through FBXO38 and KIF20B.	HIVEP1 EP400 ZBTB21 TRIM24	1.13e-04	116	74	4	30804394
Pubmed	EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis.	YAF2 SUGP2 EMSY	1.15e-04	44	74	3	27505670
Interaction	CEBPA interactions	MED15 TET2 BPTF SP4 HIVEP1 FAM120A EP400 SUGP2 PRRC2C ARID2 ZBTB21 SUGP1 CCAR1 ZMYM2 YY1AP1 ATF4 QRICH1 TRIM24 CREBBP CCNK CAPRIN1 ZYX EMSY PHF21A	2.46e-12	1245	71	24	int:CEBPA
Interaction	HDAC1 interactions	TET2 BPTF HIVEP1 ZBTB33 YAF2 EP400 RAPH1 BAZ2A ZBTB21 TNRC6A NFYC ZMYM2 AFF1 RORC NUP214 CREBBP CAPRIN1 ESCO1 EMSY PHF21A	8.29e-10	1108	71	20	int:HDAC1
Interaction	FHL2 interactions	SP2 SP4 EP400 PRRC2C NFYC CCAR1 YY1AP1 QRICH1 MAP10 CREBBP EMSY WNK3 PHF21A	1.11e-09	396	71	13	int:FHL2
Interaction	NAA40 interactions	GTF2A1 ZBTB33 EP400 RAPH1 SUGP2 BAZ2A PRRC2C ARID2 ZBTB21 AAK1 CIZ1 SUGP1 ZMYM2 NUP214 CCNK ZYX EMSY PHF21A	5.18e-09	978	71	18	int:NAA40
Interaction	KLF15 interactions	MED15 SP2 HIVEP1 EP400 PRRC2C ARID2 NFYC TRIM24 CREBBP CAPRIN1 EMSY	5.40e-09	290	71	11	int:KLF15
Interaction	AR interactions	MED15 TET2 HIVEP1 ZBTB33 EP400 SUGP2 EXPH5 ARID2 ZBTB21 BLNK SUGP1 CCAR1 ZMYM2 TRIM24 CREBBP CCNK EMSY PHF21A	6.46e-09	992	71	18	int:AR
Interaction	KLF3 interactions	BPTF HIVEP1 YAF2 EP400 ARID2 ZMYM2 RFX7 TRIM24 EMSY PHF21A	7.12e-09	228	71	10	int:KLF3
Interaction	NFYC interactions	SP2 SP4 HIVEP1 EP400 ARID2 NFYC YY1AP1 RFX7 EMSY	1.18e-08	177	71	9	int:NFYC
Interaction	EYA4 interactions	MED15 TET2 GTF2A1 TNRC6A AAK1 CIZ1 RFX7 CREBBP CCNK TAB3	1.31e-08	243	71	10	int:EYA4
Interaction	PML interactions	MED15 TET2 SP2 ZBTB33 FAM120A PTPRF EP400 AAK1 SUGP1 ZMYM2 QRICH1 TRIM24 CREBBP CAPRIN1 ZYX EMSY PHF21A	1.74e-08	933	71	17	int:PML
Interaction	KLF8 interactions	BPTF HIVEP1 EP400 PRRC2C ARID2 ZMYM2 TRIM24 CREBBP CAPRIN1 EMSY PHF21A	1.99e-08	329	71	11	int:KLF8
Interaction	WWTR1 interactions	BPTF ZBTB33 EP400 RAPH1 SUGP2 PRRC2C ARID2 STRN4 CREBBP ZYX EMSY TAB3	2.55e-08	422	71	12	int:WWTR1
Interaction	FEV interactions	SP2 HIVEP1 EP400 ARID2 YY1AP1 TRIM24 CREBBP EMSY PHF21A	3.88e-08	203	71	9	int:FEV
Interaction	TERF2IP interactions	BPTF HIVEP1 EP400 SUGP2 BAZ2A ZBTB21 CIZ1 SUGP1 CCAR1 ZMYM2 TRIM24 CREBBP EMSY	5.76e-08	552	71	13	int:TERF2IP
Interaction	PAX6 interactions	BPTF HIVEP1 YAF2 EP400 ARID2 NFYC ZMYM2 QRICH1 TRIM24 CREBBP PHF21A	5.90e-08	366	71	11	int:PAX6
Interaction	EGR2 interactions	TET2 HIVEP1 EP400 ARID2 TRIM24 CREBBP EMSY PHF21A	1.54e-07	171	71	8	int:EGR2
Interaction	NUP62CL interactions	TET2 BPTF SUGP2 TRIM24 PHF21A	1.88e-07	37	71	5	int:NUP62CL
Interaction	ETS1 interactions	BPTF HIVEP1 EP400 ARID2 TRIM24 CREBBP EMSY	2.28e-07	121	71	7	int:ETS1
Interaction	CRX interactions	MED15 TET2 SP4 EP400 ARID2 NFYC QRICH1 TRIM24 CREBBP	2.63e-07	254	71	9	int:CRX
Interaction	SMC5 interactions	BPTF HIVEP1 ZBTB33 EP400 SUGP2 BAZ2A PRRC2C ARID2 CIZ1 SUGP1 CCAR1 ZMYM2 NUP214 TRIM24 CCNK EMSY	2.92e-07	1000	71	16	int:SMC5
Interaction	HIVEP1 interactions	CACNA1A SP4 HIVEP1 NFYC QRICH1 CREBBP CCNK PHF21A	2.93e-07	186	71	8	int:HIVEP1
Interaction	SNRNP40 interactions	HIVEP1 EP400 SUGP2 BAZ2A ARID2 ZBTB21 CIZ1 SUGP1 CCAR1 QRICH1 TRIM24 EMSY PHF21A	3.00e-07	637	71	13	int:SNRNP40
Interaction	ELF1 interactions	BPTF HIVEP1 EP400 ARID2 NFYC TRIM24 EMSY	3.01e-07	126	71	7	int:ELF1
Interaction	HNF4A interactions	BPTF HIVEP1 EP400 ARID2 ZBTB21 ZMYM2 TRIM24 CREBBP EMSY	5.12e-07	275	71	9	int:HNF4A
Interaction	FHL3 interactions	MED15 SUGP2 ZBTB21 OBSCN CCAR1 QRICH1 ZYX CREB5 PHF21A	5.28e-07	276	71	9	int:FHL3
Interaction	APC interactions	GUCY2C EXPH5 STRN4 NAV2 NUP214 MBD5 MAP10 CREBBP ZYX PHF21A	1.04e-06	389	71	10	int:APC
Interaction	SP7 interactions	TET2 HIVEP1 YAF2 EP400 ARID2 SUGP1 CCAR1 TRIM24 CREBBP	1.18e-06	304	71	9	int:SP7
Interaction	PRR20E interactions	GTF2A1 SP4 HIVEP1 NFYC YY1AP1 CCNK	1.50e-06	101	71	6	int:PRR20E
Interaction	PRR20A interactions	GTF2A1 SP4 HIVEP1 NFYC YY1AP1 CCNK	2.35e-06	109	71	6	int:PRR20A
Interaction	ELF4 interactions	BPTF SP2 EP400 ARID2 TRIM24 EMSY	3.21e-06	115	71	6	int:ELF4
Interaction	TSC22D2 interactions	ARID2 ZMYM2 TSC22D2 ZYX WNK3	3.56e-06	66	71	5	int:TSC22D2
Interaction	XRCC6 interactions	BPTF GTF2A1 ZBTB33 YAF2 EP400 SUGP2 BAZ2A NFYC SUGP1 MBD5 TRIM24 CREBBP CCNK EMSY	3.63e-06	928	71	14	int:XRCC6
Interaction	HNF1B interactions	TET2 BPTF HIVEP1 EP400 ARID2 TRIM24 CREBBP	4.74e-06	190	71	7	int:HNF1B
Interaction	SOX2 interactions	TET2 SEMG2 BPTF SP2 HIVEP1 FAM120A EP400 SUGP2 ARID2 TNRC6A NAV2 ZMYM2 ATF4 NUP214 TRIM24 CCNK CAPRIN1	6.49e-06	1422	71	17	int:SOX2
Interaction	TLE3 interactions	MED15 TET2 HIVEP1 ARID2 TNRC6A CCAR1 QRICH1 CREBBP EMSY	6.69e-06	376	71	9	int:TLE3
Interaction	TGM7 interactions	NFYC QRICH1 TRIM24 WNK3	7.65e-06	36	71	4	int:TGM7
Interaction	CNOT3 interactions	MED15 PRRC2C TNRC6A TRIM24 CREBBP CAPRIN1 TAB3	8.31e-06	207	71	7	int:CNOT3
Interaction	HDAC2 interactions	TET2 BPTF YAF2 EP400 PRRC2C SUGP1 ZMYM2 CREBBP CAPRIN1 ESCO1 ZYX EMSY PHF21A	8.86e-06	865	71	13	int:HDAC2
Interaction	SRF interactions	BPTF SP2 HIVEP1 ARID2 NFYC CREBBP	9.57e-06	139	71	6	int:SRF
Interaction	FOXQ1 interactions	ZBTB33 YAF2 FAM120A SUGP2 ZMYM2 CREBBP	1.04e-05	141	71	6	int:FOXQ1
Interaction	SOX7 interactions	TET2 ARID2 TRIM24 CREBBP PHF21A	1.04e-05	82	71	5	int:SOX7
Interaction	SP2 interactions	SP2 GTF2A1 NFYC QRICH1	1.06e-05	39	71	4	int:SP2
Interaction	NUP43 interactions	BPTF HIVEP1 EP400 BAZ2A PRRC2C ARID2 CIZ1 ZMYM2 NUP214 EMSY PHF21A	1.10e-05	625	71	11	int:NUP43
Interaction	ATXN1 interactions	MED15 GTF2A1 HIVEP1 SUGP2 PRRC2C OBSCN SUGP1 CCAR1 YY1AP1 QRICH1 CREBBP CCNK CAPRIN1 ZYX	1.32e-05	1039	71	14	int:ATXN1
Interaction	NFIX interactions	BPTF HIVEP1 EP400 ARID2 QRICH1 TRIM24 EMSY	1.51e-05	227	71	7	int:NFIX
Interaction	SMG7 interactions	HIVEP1 FAM120A TNRC6A CCAR1 TRIM24 CREBBP CAPRIN1 ZYX	1.62e-05	319	71	8	int:SMG7
Interaction	PRR20B interactions	GTF2A1 SP4 HIVEP1 NFYC CCNK	1.64e-05	90	71	5	int:PRR20B
Interaction	PRR20C interactions	GTF2A1 SP4 HIVEP1 NFYC CCNK	1.64e-05	90	71	5	int:PRR20C
Interaction	PRR20D interactions	GTF2A1 SP4 HIVEP1 NFYC CCNK	1.64e-05	90	71	5	int:PRR20D
Interaction	ZYX interactions	TNRC6A AAK1 CCAR1 QRICH1 TSC22D2 ZYX WNK3 PHF21A	2.02e-05	329	71	8	int:ZYX
Interaction	FOXP3 interactions	MED15 SEMG2 BPTF SP2 ZBTB33 SUGP2 AAK1 SUGP1 NUP214	2.02e-05	432	71	9	int:FOXP3
Interaction	SP4 interactions	GTF2A1 SP4 HIVEP1 NFYC	2.06e-05	46	71	4	int:SP4
Interaction	KDM1A interactions	TET2 HIVEP1 ZBTB33 EP400 RAPH1 ZBTB21 TNRC6A LRP2 ZMYM2 NUP214 TRIM24 ESCO1 PHF21A	2.16e-05	941	71	13	int:KDM1A
Interaction	TRIM10 interactions	SEMG2 ZBTB33 EXPH5 ZMYM2	2.45e-05	48	71	4	int:TRIM10
Interaction	YWHAH interactions	PARD6B TET2 HIVEP1 YAF2 EXPH5 PRRC2C STARD9 ZBTB21 AAK1 NAV2 RFX7 CREBBP WNK3 TAB3	2.54e-05	1102	71	14	int:YWHAH
Interaction	DCP1A interactions	RAPH1 ZBTB21 TNRC6A TRIM24 ZYX PHF21A	2.62e-05	166	71	6	int:DCP1A
Interaction	YY1 interactions	BPTF HIVEP1 YAF2 EP400 ARID2 ZMYM2 TRIM24 CREBBP EMSY	2.98e-05	454	71	9	int:YY1
Interaction	SLX4 interactions	EP400 SUGP2 ZBTB21 SUGP1 ZMYM2 NUP214 TRIM24 CREBBP CREB5 EMSY	3.05e-05	572	71	10	int:SLX4
Interaction	CEBPB interactions	BPTF GTF2A1 ZBTB33 BAZ2A PRRC2C NFYC CCAR1 AFF1 ATF4 NUP214 QRICH1 TRIM24 CREBBP CAPRIN1 ZYX CREB5	3.26e-05	1443	71	16	int:CEBPB
Interaction	DUXB interactions	BPTF ZMYM2 TRIM24	3.29e-05	18	71	3	int:DUXB
Interaction	DNAAF6 interactions	YAF2 CCAR1 QRICH1	3.29e-05	18	71	3	int:DNAAF6
Interaction	MED23 interactions	MED15 EP400 TNRC6A NFYC CREBBP CCNK EMSY	4.17e-05	266	71	7	int:MED23
Interaction	ALG13 interactions	FAM120A PRRC2C TNRC6A CCAR1 CCNK ZYX	4.53e-05	183	71	6	int:ALG13
Interaction	TBXT interactions	HIVEP1 YAF2 CCAR1 TRIM24 CREBBP	5.57e-05	116	71	5	int:TBXT
Interaction	MYOD1 interactions	BPTF HIVEP1 YAF2 EP400 TRIM24 CREBBP	6.27e-05	194	71	6	int:MYOD1
Interaction	KLF5 interactions	TET2 HIVEP1 EP400 ARID2 TRIM24 CREBBP	6.45e-05	195	71	6	int:KLF5
Interaction	ELK3 interactions	SP2 SP4 HIVEP1 EP400 EMSY	6.55e-05	120	71	5	int:ELK3
Interaction	CELF1 interactions	FAM120A PRRC2C TNRC6A CIZ1 SUGP1 CCAR1 CAPRIN1	6.89e-05	288	71	7	int:CELF1
Interaction	CDH1 interactions	PTPRF RAPH1 SPRR3 AAK1 NAV2 LRRC7 NUP214 CTNND2 CREBBP CAPRIN1 ZYX	7.28e-05	768	71	11	int:CDH1
Interaction	ZNF550 interactions	SEMG2 SPRR3 STRN4 TRIM24	8.14e-05	65	71	4	int:ZNF550
Interaction	EIF4ENIF1 interactions	FAM120A PRRC2C TNRC6A TRIM24 CREBBP CAPRIN1 PHF21A	8.89e-05	300	71	7	int:EIF4ENIF1
Interaction	FOSL1 interactions	ATF4 TRIM24 CREBBP CREB5	1.09e-04	70	71	4	int:FOSL1
Interaction	FOS interactions	HIVEP1 EP400 ARID2 ATF4 TRIM24 CREBBP CREB5	1.14e-04	312	71	7	int:FOS
Interaction	RNF43 interactions	GTF2A1 SUGP2 EXPH5 TNRC6A OBSCN LRRC7 TRIM24 TAB3	1.26e-04	427	71	8	int:RNF43
Interaction	ERG interactions	TET2 HIVEP1 ZMYM2 TRIM24 CREBBP EMSY	1.35e-04	223	71	6	int:ERG
Interaction	SIAH1 interactions	PARD6B RAPH1 KIAA0319L AFF1 QRICH1 ZYX	1.35e-04	223	71	6	int:SIAH1
Interaction	GATAD2A interactions	BPTF FAM120A TNRC6A SUGP1 CREBBP CAPRIN1	1.38e-04	224	71	6	int:GATAD2A
Interaction	WNK1 interactions	TSC22D1 TNRC6A AAK1 ZYX WNK3	1.40e-04	141	71	5	int:WNK1
Interaction	FOXK2 interactions	BPTF FAM120A PRRC2C NFYC ZYX EMSY	1.42e-04	225	71	6	int:FOXK2
Interaction	SS18L2 interactions	CIZ1 ZMYM2 YY1AP1 MBD5	1.50e-04	76	71	4	int:SS18L2
Interaction	FBXO38 interactions	HIVEP1 EP400 ZBTB21 TRIM24 CREBBP	1.60e-04	145	71	5	int:FBXO38
Interaction	NCOA6 interactions	MED15 GTF2A1 TNRC6A RORC CREBBP	1.60e-04	145	71	5	int:NCOA6
Interaction	VPS72 interactions	TET2 EP400 WDR7 NFYC TRIM24	1.65e-04	146	71	5	int:VPS72
Interaction	ELF5 interactions	BPTF ARID2 ZMYM2 TRIM24 EMSY	1.71e-04	147	71	5	int:ELF5
Interaction	SMAD3 interactions	MED15 BPTF HIVEP1 NFYC ZMYM2 NUP214 TRIM24 CREBBP	1.72e-04	447	71	8	int:SMAD3
Interaction	YWHAZ interactions	PARD6B TET2 HIVEP1 ZBTB33 YAF2 RAPH1 WDR7 EXPH5 STARD9 WASF3 ZBTB21 AAK1 NAV2 TAB3	1.76e-04	1319	71	14	int:YWHAZ
Interaction	FOXJ2 interactions	NFYC ZMYM2 QRICH1 EMSY	1.92e-04	81	71	4	int:FOXJ2
Interaction	NUP50 interactions	GTF2A1 TSC22D1 BAZ2A ARID2 SUGP1 NUP214 CCNK	1.96e-04	341	71	7	int:NUP50
Interaction	RAD18 interactions	BPTF FAM120A PRRC2C SUGP1 CCAR1 ZMYM2 TRIM24 CCNK	2.00e-04	457	71	8	int:RAD18
Interaction	YWHAB interactions	PARD6B TET2 HIVEP1 YAF2 EXPH5 STARD9 WASF3 ZBTB21 AAK1 NAV2 RFX7 ZYX	2.02e-04	1014	71	12	int:YWHAB
Interaction	PHF21A interactions	HIVEP1 ZBTB33 TNRC6A ZMYM2 NUP214 ZYX PHF21A	2.03e-04	343	71	7	int:PHF21A
Interaction	RNF2 interactions	MED15 ZBTB33 YAF2 FAM120A EP400 SUGP2 TSC22D2 TRIM24 CAPRIN1 EMSY PHF21A	2.09e-04	866	71	11	int:RNF2
Interaction	HSFY1 interactions	NFYC QRICH1 CCNK	2.32e-04	34	71	3	int:HSFY1
Interaction	ASF1A interactions	HIVEP1 EP400 ARID2 SUGP1 TRIM24 EMSY	2.45e-04	249	71	6	int:ASF1A
Interaction	NHLH1 interactions	BPTF HIVEP1 EP400 ZBTB21	2.64e-04	88	71	4	int:NHLH1
Interaction	H3C1 interactions	BPTF BAZ2A PRRC2C ARID2 NAV2 ZMYM2 MBD5 TRIM24 CREBBP ESCO1 ITIH2	2.94e-04	901	71	11	int:H3C1
Interaction	SEMG1 interactions	TET2 SEMG2 PTPRF LRP2	3.00e-04	91	71	4	int:SEMG1
Interaction	TNKS1BP1 interactions	TNRC6A CCAR1 TRIM24 ZYX PHF21A	3.17e-04	168	71	5	int:TNKS1BP1
Interaction	BAG2 interactions	BPTF EXPH5 PRRC2C AAK1 CIZ1 NFYC QRICH1 CREBBP WNK3	3.24e-04	622	71	9	int:BAG2
Interaction	KLF6 interactions	EP400 ARID2 TRIM24 EMSY	3.54e-04	95	71	4	int:KLF6
GeneFamily	Ataxins\|Trinucleotide repeat containing	MED15 EP400 TNRC6A	3.88e-05	25	48	3	775
GeneFamily	PHD finger proteins	BPTF BAZ2A TRIM24 PHF21A	9.45e-05	90	48	4	88
GeneFamily	Zinc fingers C2H2-type\|Sp transcription factors	SP2 SP4	2.46e-04	9	48	2	755
GeneFamily	Zinc fingers CXXC-type\|Methyl-CpG binding domain containing	BAZ2A MBD5	3.74e-04	11	48	2	1025
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	YAF2 TAB3	1.40e-03	21	48	2	89
GeneFamily	G-patch domain containing\|Minor histocompatibility antigens	SUGP2 SUGP1	1.54e-03	22	48	2	579
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	BPTF HIVEP1 YAF2 WDR7 PRRC2C WASF3 NFYC ZMYM2 AFF1 TSC22D2 TRIM24 CREBBP CREB5 PHF21A	5.00e-08	856	70	14	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	BPTF HIVEP1 WDR7 PRRC2C WASF3 NFYC ZMYM2 AFF1 CREBBP PHF21A	4.38e-07	466	70	10	M13522
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TET2 BPTF FAM120A BAZ2A PRRC2C RFX7 CREBBP	5.33e-07	180	70	7	M8239
Coexpression	GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN	SP4 BAZ2A PRRC2C TNRC6A ZMYM2 RFX7	2.15e-06	141	70	6	M7720
Coexpression	BENPORATH_SOX2_TARGETS	CACNA1A SP2 TSC22D1 SUGP2 EXPH5 KIAA0319L TNRC6A LRP2 ATF4 TRIM24 CAPRIN1	3.71e-06	734	70	11	M3835
Coexpression	GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP	MED15 TSC22D1 BAZ2A AFF1 RFX7 PHF21A	1.43e-05	196	70	6	M4530
Coexpression	GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP	SP2 KIAA0319L CIZ1 LRRC7 ZYX	3.83e-05	141	70	5	M466
Coexpression	GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN	PRRC2C ARID2 TNRC6A AFF1 CREBBP	6.40e-05	157	70	5	M7733
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	BPTF HIVEP1 PRRC2C ARID2 TNRC6A MBD5 TRIM24	2.53e-08	193	71	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 BLNK LRP2 CTNND2	5.62e-07	188	71	6	beb2df2332a46cc81b10e8e29fc9829020111f03
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	BPTF HIVEP1 ARID2 TNRC6A MBD5 TRIM24	6.35e-07	192	71	6	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 BLNK LRP2 CTNND2	6.35e-07	192	71	6	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	BPTF SUGP2 PRRC2C AAK1 CCAR1 ATF4	6.35e-07	192	71	6	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	BPTF ZBTB33 FAM120A BAZ2A AFF1 CAPRIN1	6.55e-07	193	71	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	PCW_10-12-Epithelial-Epithelial_airway\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 BLNK LRP2 CTNND2	7.60e-07	198	71	6	9a12e5e47236433e512c668005fe3f8be6fde95c
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	PARD6B PTPRF EXPH5 NAV2 CTNND2	9.92e-06	179	71	5	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	droplet-Marrow-BM-1m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF OBSCN BLNK CTNND2	1.05e-05	181	71	5	fb64da1dde37fe6ba7de2586cd58848ac1974f24
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	PARD6B PTPRF EXPH5 NAV2 CTNND2	1.10e-05	183	71	5	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PTPRF EXPH5 BLNK LRP2 CTNND2	1.10e-05	183	71	5	c5b10571599dc26476170b54b53f09c23e6b3117
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PARD6B PTPRF WASF3 NAV2 CTNND2	1.16e-05	185	71	5	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	BPTF BAZ2A PRRC2C AAK1 WNK3	1.16e-05	185	71	5	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	facs-Lung-EPCAM-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRF PRRC2C LRP2 NAV2 CTNND2	1.19e-05	186	71	5	7c4eb769574f9f32753cea1cc38c711dabba88b9
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	PARD6B PTPRF WASF3 NAV2 CTNND2	1.19e-05	186	71	5	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PARD6B PTPRF WASF3 NAV2 CTNND2	1.23e-05	187	71	5	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 LRP2 CTNND2	1.23e-05	187	71	5	db2974e2e87ac9f1c2407a371d5ed89af09fc9b7
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 BLNK CTNND2	1.26e-05	188	71	5	0d86044bc340e3efb90d0022dd299873639d831c
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PTPRF EXPH5 BLNK LRP2 CTNND2	1.29e-05	189	71	5	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PARD6B PTPRF WASF3 NAV2 CTNND2	1.32e-05	190	71	5	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 LRP2 CTNND2	1.32e-05	190	71	5	c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 LRP2 CTNND2	1.32e-05	190	71	5	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PTPRF EXPH5 BLNK LRP2 CTNND2	1.36e-05	191	71	5	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 LRP2 CTNND2	1.39e-05	192	71	5	d3634574b2e8d2ded6446969361b70761b331aea
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 LRP2 CTNND2	1.39e-05	192	71	5	b7c01e12b3e9be960a741b08835f1dfff65d0d47
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 LRP2 CTNND2	1.39e-05	192	71	5	1aa5e4d9b32013a3f272561dcb8377f6805706df
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 LRP2 CTNND2	1.43e-05	193	71	5	ab78fb1603ea6f720ba2d30148fe65dccf271fe1
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PARD6B EXPH5 BLNK LRP2 CTNND2	1.43e-05	193	71	5	b25cdca3a1e381784ae48ca73c51cbb6ac62b811
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PARD6B EXPH5 BLNK LRP2 CTNND2	1.43e-05	193	71	5	b38aaffbea36ef6c08ebe82675438f873c89b242
ToppCell	PCW_05-06-Epithelial-Epithelial_airway\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PTPRF EXPH5 BLNK LRP2 CTNND2	1.43e-05	193	71	5	af6ec2c2ba92aef3e41531c3c7215b3300437bd9
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PTPRF EXPH5 BLNK LRP2 CTNND2	1.46e-05	194	71	5	b19e16a76d7342ff9a665d19c9151652916f17d4
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 LRP2 CTNND2	1.46e-05	194	71	5	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PTPRF EXPH5 BLNK LRP2 CTNND2	1.46e-05	194	71	5	f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A FAM120A PTPRF PRRC2C NAV2	1.50e-05	195	71	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 LRP2 CTNND2	1.50e-05	195	71	5	98dd3b7d5ef587825dac052dea4d4ff883f6d4d6
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 LRP2 CTNND2	1.50e-05	195	71	5	ce1ba5911e8a6ddb07434acc37147c38e94245ff
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A FAM120A PTPRF PRRC2C NAV2	1.50e-05	195	71	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	PCW_13-14-Epithelial-Epithelial_proliferating\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 LRP2 CTNND2	1.54e-05	196	71	5	7b17d47b7758d8ccf9dbefd097aeb553791a1eed
ToppCell	11.5-Distal-Epithelial-Bud_tip_adjacent\|Distal / Age, Tissue, Lineage and Cell class	PARD6B PTPRF EXPH5 BLNK CTNND2	1.54e-05	196	71	5	a6a242868df0d2ff30825624a8d7c0367527594d
ToppCell	PCW_10-12-Epithelial\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PARD6B PTPRF EXPH5 LRP2 CTNND2	1.54e-05	196	71	5	9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	BPTF FAM120A PTPRF TRIM24 CREB5	1.65e-05	199	71	5	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	AFMID ARID2 ZBTB21 MAP10	8.73e-05	146	71	4	1bf67a9416f52198931b912a31be4bab09fefd19
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	AFMID ARID2 ZBTB21 MAP10	1.02e-04	152	71	4	b8aa62e3cf2b4c252db4bccfa75d881c4fa0a788
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT1_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	PTPRF EXPH5 RORC ITIH2	1.07e-04	154	71	4	8a643d91896af9b630a715fb284c1523d01ad1a3
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 NAV2 DRC1 TSC22D2	1.13e-04	156	71	4	4d2679e7639758c49fc25a2deb9109b08f0a3e57
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PARD6B PTPRF MROH5 NAV2	1.30e-04	162	71	4	d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PARD6B PTPRF MROH5 NAV2	1.30e-04	162	71	4	06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EXPH5 SUGP1 RORC LRRC7	1.37e-04	164	71	4	76b0ac220b7ca22fbea28a507f01f96ae9f53932
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EXPH5 SUGP1 RORC LRRC7	1.37e-04	164	71	4	911081739174ec68bc0893c804e4276b206bea7d
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EXPH5 SUGP1 RORC LRRC7	1.37e-04	164	71	4	c5bfae7e9497185548c243d6f9ebadbcef48ba7f
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	EXPH5 BLNK LRP2 CTNND2	1.47e-04	167	71	4	25af48c640e67848594f5902867ba325fc105da4
ToppCell	droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cells\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 OBSCN BLNK CTNND2	1.50e-04	168	71	4	e8878ec68b21c8d5694d7209b816d2f869673164
ToppCell	droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 OBSCN BLNK CTNND2	1.50e-04	168	71	4	a007758c219d3d5db2b5529f29af63be0d408304
ToppCell	droplet-Lung-nan-18m-Myeloid-Plasmacytoid_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF BLNK CTNND2	1.57e-04	170	71	4	749144a1a869a6bf9acdd227184319083367dc3f
ToppCell	droplet-Lung-nan-18m-Myeloid-plasmacytoid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF BLNK CTNND2	1.57e-04	170	71	4	25d60a62e8f99c31ab64fe6a0c07ccca3df1a7ee
ToppCell	facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF CTNND2 TRIM24	1.60e-04	171	71	4	6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794
ToppCell	droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF OBSCN CTNND2	1.60e-04	171	71	4	4e856441063e9825b6f87a1d3dd19c77dae4662c
ToppCell	facs-Marrow-T-cells-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF CTNND2 TRIM24	1.60e-04	171	71	4	e02b5831768dbb1b68998b672e55c9680ab0cc86
ToppCell	droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TSC22D1 PTPRF BLNK CTNND2	1.64e-04	172	71	4	422d311bba2dd5d8bece4e96ee8c86e78086b62d
ToppCell	droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 OBSCN BLNK CTNND2	1.64e-04	172	71	4	24ecfda5e43e28f190089770cd2eae5bf2ed292b
ToppCell	droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cells\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 OBSCN BLNK CTNND2	1.64e-04	172	71	4	db5a31cafce4346fe459d7f35210823fd7004439
ToppCell	droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TSC22D1 PTPRF BLNK CTNND2	1.64e-04	172	71	4	1abb6fbb28c8aff384540493d0f70eeacaa751f4
ToppCell	droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF OBSCN CTNND2	1.75e-04	175	71	4	21bc0e59a9509d38751ce6aad2325f341bc70eff
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF BLNK CTNND2	1.79e-04	176	71	4	d4075796c38b775fe721abb47426e662a0d415e3
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF BLNK CTNND2	1.91e-04	179	71	4	87a69f9f83b8f0c028a4874acb238f2e079bf51f
ToppCell	droplet-Marrow-nan-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF BLNK CTNND2	1.91e-04	179	71	4	dcaf2191134a586d50ebaf67dcf5b815b54a722b
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF BLNK CTNND2	1.91e-04	179	71	4	1757b9f3f4c634277a67c4f5a39d27d6b4937073
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RAPH1 AAK1 BLNK POM121L2	1.91e-04	179	71	4	d3438fed0d85d5ed5afa8ff820c45143d77b6c0d
ToppCell	droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF OBSCN CTNND2	1.91e-04	179	71	4	d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159
ToppCell	facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF OBSCN CTNND2	1.95e-04	180	71	4	bf8d13d4db1af55b8c9fe16aaccf8743e000e005
ToppCell	facs-Marrow-B-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF OBSCN CTNND2	1.95e-04	180	71	4	839defb40f7cfb2711e9025194de636533f51bcd
ToppCell	facs-Marrow-B-cells-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF OBSCN CTNND2	1.95e-04	180	71	4	82965ed1b72a1873c24dd4553d39681596057316
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF BLNK CTNND2	1.95e-04	180	71	4	df60970520fba2ac0639faa54096766d07418ca4
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF BLNK CTNND2	1.95e-04	180	71	4	64f01494a4052186773720e10b4e7c724ff94547
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	AFMID CACNA1A TNRC6A LRP2	1.99e-04	181	71	4	c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF BLNK CTNND2	2.04e-04	182	71	4	33afbb7c4352b03266501b1f4f0e751c12c7350d
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PARD6B PTPRF EXPH5 NAV2	2.04e-04	182	71	4	573771130247e869e4e58f22d4a1cb31989635cf
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PARD6B PTPRF EXPH5 NAV2	2.04e-04	182	71	4	6cfaa2b3b3974c13b01c943f4adb70768dcc35e4
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	MED15 CACNA1A CIZ1 EMSY	2.12e-04	184	71	4	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	P28-Epithelial\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PARD6B PTPRF LRP2 NAV2	2.12e-04	184	71	4	05811d13bd8a602095a3fcf5e55345edadc7b8bf
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRF WASF3 NAV2 CTNND2	2.12e-04	184	71	4	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRF WASF3 NAV2 CTNND2	2.12e-04	184	71	4	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 PTPRF BLNK CTNND2	2.17e-04	185	71	4	65dcb0a7ee64990a34a87c167b44497107f035ee
ToppCell	P28-Epithelial-alveolar_epithelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PARD6B PTPRF LRP2 NAV2	2.17e-04	185	71	4	5bb513e569f3a197d55ae2ca683e202daebabeac
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP1 AFF1 ATF4 TSC22D2	2.17e-04	185	71	4	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	AFMID KIAA0319L CTNND2 ITIH2	2.17e-04	185	71	4	1d874608aa2062024323512f68889219471b2f00
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PTPRF EXPH5 BLNK LRP2	2.21e-04	186	71	4	bb0bfe9a015151be08a6ffc5d82896d0556d76de
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PARD6B PTPRF NAV2 RORC	2.21e-04	186	71	4	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PARD6B PTPRF NAV2 RORC	2.21e-04	186	71	4	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	KIAA0319L TNRC6A CTNND2 MBD5	2.26e-04	187	71	4	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	PND03\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAK PTPRF NAV2 DRC1	2.26e-04	187	71	4	b3fcb36d853adfdea7172c5591de06f027e50af3
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	PARD6B PTPRF WASF3 CTNND2	2.26e-04	187	71	4	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TSC22D1 EXPH5 BLNK TSC22D2	2.31e-04	188	71	4	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	TSC22D1 OBSCN LRRC7 CTNND2	2.31e-04	188	71	4	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TSC22D1 EXPH5 BLNK TSC22D2	2.31e-04	188	71	4	bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PARD6B PTPRF NAV2 RORC	2.31e-04	188	71	4	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	PARD6B PTPRF EXPH5 NAV2	2.31e-04	188	71	4	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PARD6B TSC22D1 EXPH5 LRRC7	2.35e-04	189	71	4	1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 BLNK NAV2 TSC22D2	2.35e-04	189	71	4	7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PARD6B EXPH5 LRP2 CTNND2	2.35e-04	189	71	4	5d9da836ce4308b8458bb3be3871a0aca734b6cd
Drug	Benserazide hydrochloride [14919-77-8]; Up 200; 13.6uM; PC3; HT_HG-U133A	GTF2A1 MAK BAZ2A AAK1 SUGP1 POM121L2 CTNND2 CREBBP	1.63e-07	197	70	8	6722_UP
Drug	Iodipamide [606-17-7]; Up 200; 3.6uM; MCF7; HT_HG-U133A	CACNA1A BAZ2A AAK1 SUGP1 NUP214 TSC22D2 ZYX	2.39e-06	196	70	7	5510_UP
Drug	Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A	PARD6B SP4 KIAA0319L BLNK ZMYM2 RORC CCNK	2.39e-06	196	70	7	2250_UP
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A	CACNA1A ZBTB33 BAZ2A KIAA0319L SUGP1 EMSY ITIH2	2.47e-06	197	70	7	3930_DN
Drug	Gossypol [303-45-7]; Up 200; 7.8uM; PC3; HT_HG-U133A	AAK1 SUGP1 ZMYM2 ATF4 TSC22D2 CREB5	2.47e-05	188	70	6	4296_UP
Drug	Azacytidine-5 [320-67-2]; Up 200; 16.4uM; PC3; HT_HG-U133A	TSC22D1 BAZ2A SUGP1 TSC22D2 CTNND2 CREB5	2.47e-05	188	70	6	4010_UP
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	BAZ2A EXPH5 SUGP1 LRP2 ZMYM2 CREB5	2.70e-05	191	70	6	4279_DN
Drug	Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A	SEMG2 BAZ2A SPRR3 BLNK NUP214 ITIH2	2.87e-05	193	70	6	3370_UP
Drug	Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	MED15 PTPRF BAZ2A SUGP1 LRP2 EMSY	2.95e-05	194	70	6	4107_DN
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A	PARD6B BAZ2A EXPH5 KIAA0319L NUP214 ITIH2	3.04e-05	195	70	6	4345_DN
Drug	Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	GTF2A1 PTPRF SUGP2 TRIM24 EMSY PHF21A	3.04e-05	195	70	6	7451_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	MAK AAK1 BLNK POM121L2 TSC22D2 CCNK	3.04e-05	195	70	6	5576_UP
Drug	PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A	GTF2A1 ZBTB33 SUGP1 ZMYM2 AFF1 CTNND2	3.13e-05	196	70	6	4291_UP
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; HL60; HG-U133A	TSC22D1 BAZ2A CIZ1 STRN4 SUGP1 PHF21A	3.13e-05	196	70	6	1558_DN
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A	BAZ2A NAV2 NUP214 ZYX CREB5 EMSY	3.22e-05	197	70	6	5835_UP
Drug	Iopromide [73334-07-3]; Up 200; 5uM; MCF7; HT_HG-U133A	CACNA1A BAZ2A KIAA0319L AFF1 POM121L2 CCNK	3.22e-05	197	70	6	6842_UP
Drug	Pizotifen malate [5189-11-7]; Up 200; 9.4uM; HL60; HT_HG-U133A	SEMG2 SPRR3 TSC22D2 CTNND2 CCNK ITIH2	3.31e-05	198	70	6	3134_UP
Drug	Diperodon hydrochloride [537-12-2]; Up 200; 9.2uM; PC3; HT_HG-U133A	SEMG2 ZBTB33 KIAA0319L CIZ1 POM121L2 CCNK	3.31e-05	198	70	6	4498_UP
Drug	Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; HL60; HT_HG-U133A	BAZ2A AFF1 NUP214 CREBBP CCNK ITIH2	3.40e-05	199	70	6	2449_UP
Drug	Methazolamide [554-57-4]; Down 200; 17uM; MCF7; HT_HG-U133A	MED15 SP2 WDR7 PRRC2C NUP214 ZYX	3.40e-05	199	70	6	6268_DN
Drug	Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; MCF7; HT_HG-U133A	MED15 SUGP1 NAV2 ZMYM2 CTNND2 ZYX	3.40e-05	199	70	6	7215_DN
Drug	Xylazine [7361-61-7]; Down 200; 18.2uM; HL60; HT_HG-U133A	GTF2A1 SUGP2 BAZ2A SUGP1 ZMYM2 POM121L2	3.40e-05	199	70	6	2132_DN
Drug	Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	GTF2A1 EXPH5 AAK1 SUGP1 NUP214 TSC22D2	3.40e-05	199	70	6	7025_DN
Drug	Piperacetazine [3819-00-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A	MED15 PTPRF SUGP2 BAZ2A STRN4 ZYX	3.40e-05	199	70	6	7191_DN
Drug	Chloroprene	BPTF RAPH1 ARID2 AAK1 BLNK LRP2 NAV2 CCAR1 RORC QRICH1 CREBBP ESCO1 EMSY ITIH2	5.16e-05	1348	70	14	ctd:D002737
Drug	heptene	AFMID SP2	1.39e-04	6	70	2	CID000011610
Drug	geldanamycin	TET2 GTF2A1 SP4 PRRC2C RFX7 CCNK ESCO1	1.43e-04	371	70	7	ctd:C001277
Drug	Strophanthidin [66-28-4]; Up 200; 9.8uM; PC3; HT_HG-U133A	TSC22D1 MAK ATF4 TSC22D2 CREB5	1.60e-04	166	70	5	5826_UP
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	BPTF NAV2 ZMYM2 TRIM24 PHF21A	1.84e-04	171	70	5	7535_DN
Drug	6-fluoranyl-7H-purine	AFMID SP2	1.94e-04	7	70	2	CID005462117
Drug	Vigabatrin [60643-86-9]; Up 200; 31uM; HL60; HT_HG-U133A	GTF2A1 BAZ2A KIAA0319L AFF1 CREBBP	1.99e-04	174	70	5	2452_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	BPTF SUGP2 STRN4 SUGP1 CREBBP	1.99e-04	174	70	5	5693_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BPTF SUGP1 QRICH1 CREBBP ZYX	2.10e-04	176	70	5	1212_DN
Drug	staurosporine; Up 200; 0.1uM; MCF7; HG-U133A	SUGP2 NAV2 AFF1 ZYX ITIH2	2.10e-04	176	70	5	423_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BPTF STRN4 NFYC QRICH1 CREBBP	2.22e-04	178	70	5	7245_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	BPTF STRN4 NFYC QRICH1 CREBBP	2.22e-04	178	70	5	992_DN
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA	PARD6B SUGP2 SUGP1 ZMYM2 TSC22D2	2.78e-04	187	70	5	972_DN
Drug	colchicine; Up 200; 1uM; SKMEL5; HG-U133A	BPTF BAZ2A PRRC2C AAK1 TSC22D2	2.99e-04	190	70	5	630_UP
Drug	Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A	PTPRF BAZ2A CIZ1 SUGP1 ZYX	3.07e-04	191	70	5	7220_DN
Drug	Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A	GTF2A1 PRRC2C SUGP1 LRP2 RFX7	3.14e-04	192	70	5	4104_DN
Drug	Betamethasone [378-44-9]; Up 200; 10.2uM; PC3; HT_HG-U133A	BAZ2A CIZ1 NAV2 POM121L2 CTNND2	3.14e-04	192	70	5	6728_UP
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A	KIAA0319L SUGP1 LRP2 ZYX ITIH2	3.22e-04	193	70	5	4286_DN
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; PC3; HT_HG-U133A	KIAA0319L AFF1 NUP214 ZYX CREB5	3.22e-04	193	70	5	4226_DN
Drug	Ursolic acid [77-52-1]; Up 200; 8.8uM; PC3; HT_HG-U133A	CACNA1A SUGP1 LRP2 ZMYM2 RFX7	3.22e-04	193	70	5	2067_UP
Drug	Myosmine [532-12-7]; Down 200; 27.4uM; MCF7; HT_HG-U133A	SUGP2 KIAA0319L SUGP1 CCNK ITIH2	3.22e-04	193	70	5	3634_DN
Drug	(+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA	CACNA1A KIAA0319L SUGP1 LRP2 PHF21A	3.30e-04	194	70	5	954_UP
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	MED15 EP400 KIAA0319L SUGP1 CCNK	3.30e-04	194	70	5	1060_UP
Drug	Roxithromycin [80214-83-1]; Down 200; 4.8uM; PC3; HT_HG-U133A	GTF2A1 BAZ2A KIAA0319L NUP214 CTNND2	3.30e-04	194	70	5	4192_DN
Drug	Iopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A	MED15 KIAA0319L STRN4 SUGP1 NAV2	3.30e-04	194	70	5	3527_DN
Drug	Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; HL60; HT_HG-U133A	GTF2A1 MAK AAK1 SUGP1 ITIH2	3.30e-04	194	70	5	6160_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A	PARD6B AAK1 SUGP1 NUP214 CCNK	3.30e-04	194	70	5	2223_UP
Drug	Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A	PARD6B GTF2A1 AAK1 LRP2 AFF1	3.30e-04	194	70	5	2844_UP
Drug	ICRF-154	AFMID AFF1	3.31e-04	9	70	2	CID000072760
Drug	Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A	GTF2A1 SUGP2 BLNK TSC22D2 EMSY	3.37e-04	195	70	5	4412_DN
Drug	Prednisone [53-03-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	SUGP2 EXPH5 LRP2 NUP214 ZYX	3.37e-04	195	70	5	1478_DN
Drug	Riboflavine [83-88-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A	BAZ2A SPRR3 AAK1 AFF1 CCNK	3.37e-04	195	70	5	6822_UP
Drug	5-aza-2′-deoxycytidine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	PARD6B ZBTB33 SUGP2 CTNND2 CREB5	3.37e-04	195	70	5	920_UP
Drug	Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A	PARD6B AAK1 SUGP1 LRP2 EMSY	3.37e-04	195	70	5	4399_DN
Drug	Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; HL60; HT_HG-U133A	CACNA1A SUGP2 EXPH5 TSC22D2 EMSY	3.37e-04	195	70	5	1330_DN
Drug	Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A	PARD6B GTF2A1 SUGP2 SUGP1 TSC22D2	3.37e-04	195	70	5	5329_DN
Drug	Cisapride [81098-60-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	CACNA1A LRP2 ZMYM2 TSC22D2 CCNK	3.45e-04	196	70	5	3305_UP
Drug	Idoxuridine [54-42-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	GTF2A1 SUGP2 KIAA0319L NUP214 ZYX	3.45e-04	196	70	5	4200_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A	SUGP2 KIAA0319L STRN4 ZYX ITIH2	3.45e-04	196	70	5	4292_DN
Drug	0317956-0000 [391210-11-0]; Up 200; 10uM; PC3; HT_HG-U133A	GTF2A1 SP4 BAZ2A ZMYM2 TSC22D2	3.45e-04	196	70	5	4331_UP
Drug	Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	CACNA1A BAZ2A CIZ1 STRN4 CREB5	3.45e-04	196	70	5	4594_DN
Drug	Piretanide [55837-27-9]; Up 200; 11uM; PC3; HT_HG-U133A	ZBTB33 KIAA0319L CIZ1 TSC22D2 ITIH2	3.45e-04	196	70	5	4490_UP
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; HL60; HG-U133A	BAZ2A AAK1 CIZ1 SUGP1 ZMYM2	3.45e-04	196	70	5	2005_DN
Drug	Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A	HIVEP1 AAK1 POM121L2 NUP214 CTNND2	3.45e-04	196	70	5	7269_UP
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A	HIVEP1 PTPRF CIZ1 LRP2 CTNND2	3.45e-04	196	70	5	5523_DN
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; PC3; HT_HG-U133A	ZBTB33 KIAA0319L STRN4 LRP2 POM121L2	3.45e-04	196	70	5	4508_UP
Drug	Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	GTF2A1 SUGP1 LRP2 ZMYM2 TSC22D2	3.45e-04	196	70	5	4840_DN
Drug	Terconazole [67915-31-5]; Up 200; 7.6uM; HL60; HT_HG-U133A	ZBTB33 KIAA0319L NAV2 TSC22D2 CCNK	3.45e-04	196	70	5	2484_UP
Drug	CP-645525-01 [287190-82-3]; Down 200; 10uM; MCF7; HT_HG-U133A	KIAA0319L CIZ1 NAV2 AFF1 EMSY	3.54e-04	197	70	5	7522_DN
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A	PARD6B SUGP2 SUGP1 CTNND2 EMSY	3.54e-04	197	70	5	3319_DN
Drug	Ciprofibrate [52214-84-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	SUGP1 NUP214 TSC22D2 CAPRIN1 ZYX	3.54e-04	197	70	5	3561_DN
Drug	AH6809; Up 200; 1uM; PC3; HT_HG-U133A	SUGP2 BAZ2A KIAA0319L NUP214 CTNND2	3.54e-04	197	70	5	7049_UP
Drug	Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A	BAZ2A EXPH5 KIAA0319L SUGP1 NUP214	3.54e-04	197	70	5	7197_DN
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A	ZBTB33 SUGP2 BAZ2A CREB5 ITIH2	3.54e-04	197	70	5	3801_DN
Drug	Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A	GTF2A1 BAZ2A EXPH5 CIZ1 SUGP1	3.54e-04	197	70	5	6455_DN
Drug	Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A	KIAA0319L BLNK LRP2 NUP214 CCNK	3.54e-04	197	70	5	3304_UP
Drug	Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	PARD6B KIAA0319L SUGP1 POM121L2 TSC22D2	3.54e-04	197	70	5	3339_UP
Drug	Naproxen [22204-53-1]; Down 200; 17.4uM; PC3; HT_HG-U133A	EP400 BAZ2A PRRC2C CIZ1 SUGP1	3.54e-04	197	70	5	1828_DN
Drug	Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A	GTF2A1 FAM120A PTPRF KIAA0319L SUGP1	3.54e-04	197	70	5	6758_DN
Drug	Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	GTF2A1 BAZ2A KIAA0319L AAK1 LRP2	3.54e-04	197	70	5	3247_UP
Drug	Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A	SUGP2 BAZ2A CIZ1 SUGP1 LRP2	3.54e-04	197	70	5	5500_DN
Drug	Bisacodyl [603-50-9]; Up 200; 11uM; HL60; HT_HG-U133A	GTF2A1 KIAA0319L SUGP1 LRP2 AFF1	3.54e-04	197	70	5	2435_UP
Drug	Carteolol hydrochloride [51781-21-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A	HIVEP1 BAZ2A SUGP1 EMSY PHF21A	3.62e-04	198	70	5	3276_UP
Drug	Nadide [53-84-9]; Down 200; 6uM; HL60; HT_HG-U133A	CACNA1A EXPH5 SUGP1 POM121L2 TSC22D2	3.62e-04	198	70	5	2529_DN
Drug	Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; PC3; HT_HG-U133A	SP2 SUGP2 WASF3 SUGP1 NUP214	3.62e-04	198	70	5	7275_DN
Drug	Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	GTF2A1 SP4 SUGP1 ZMYM2 CCNK	3.62e-04	198	70	5	4343_UP
Drug	Morantel tartrate [26155-31-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	PARD6B BAZ2A AAK1 SUGP1 NUP214	3.62e-04	198	70	5	7010_DN
Drug	Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; HL60; HT_HG-U133A	BAZ2A AAK1 RORC CREBBP ITIH2	3.62e-04	198	70	5	2521_UP
Drug	colcemid; Down 200; 11.7uM; MCF7; HT_HG-U133A_EA	PARD6B NFYC SUGP1 ZMYM2 CREBBP	3.62e-04	198	70	5	1103_DN
Drug	Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A	BAZ2A SUGP1 AFF1 NUP214 EMSY	3.62e-04	198	70	5	3359_UP
Drug	Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; MCF7; HT_HG-U133A	GTF2A1 BAZ2A AAK1 SUGP1 EMSY	3.62e-04	198	70	5	5609_DN
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A	GTF2A1 SUGP1 ZMYM2 AFF1 CTNND2	3.62e-04	198	70	5	4301_UP
Drug	5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA	MED15 GTF2A1 WDR7 PRRC2C KIAA0319L	3.62e-04	198	70	5	889_DN
Drug	Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SUGP2 BAZ2A SUGP1 TSC22D2 CTNND2	3.62e-04	198	70	5	7169_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	PTPRF SUGP2 KIAA0319L SUGP1 ZYX	3.62e-04	198	70	5	5242_DN
Drug	Syrosingopine [84-36-6]; Down 200; 6uM; HL60; HG-U133A	SP2 SUGP2 BAZ2A PRRC2C CIZ1	3.62e-04	198	70	5	1761_DN
Disease	macula measurement	BPTF TNRC6A LRP2 NAV2 TSC22D2 CTNND2	6.46e-06	189	71	6	EFO_0008375
Disease	cortical surface area measurement	CACNA1A TET2 SP4 PTPRF RAPH1 PRRC2C TNRC6A NAV2 CCAR1 AFF1 TSC22D2 PHF21A	8.11e-05	1345	71	12	EFO_0010736
Disease	serum gamma-glutamyl transferase measurement	PARD6B BPTF NAV2 AFF1 YY1AP1 RORC ZYX CREB5 EMSY	3.37e-04	914	71	9	EFO_0004532
Disease	triglycerides in LDL measurement	BPTF SUGP1 AFF1	3.38e-04	56	71	3	EFO_0022320
Disease	neuroticism measurement, cognitive function measurement	TET2 HIVEP1 FAM120A TNRC6A NAV2 TSC22D2 CTNND2	4.24e-04	566	71	7	EFO_0007660, EFO_0008354
Disease	triglyceride measurement, phospholipid measurement	BPTF SUGP1 AFF1 TSC22D2	4.32e-04	146	71	4	EFO_0004530, EFO_0004639
Disease	triglycerides in small VLDL measurement	BPTF SUGP1 AFF1	4.35e-04	61	71	3	EFO_0022145
Disease	triglycerides in medium LDL measurement	BPTF SUGP1 AFF1	4.56e-04	62	71	3	EFO_0022322
Disease	triglycerides to total lipids in very large HDL percentage	BPTF SUGP1 AFF1	4.56e-04	62	71	3	EFO_0022339
Disease	triglycerides in small HDL measurement	BPTF SUGP1 AFF1	4.56e-04	62	71	3	EFO_0022158
Disease	triglycerides in small LDL measurement	BPTF SUGP1 AFF1	5.24e-04	65	71	3	EFO_0022323
Disease	myelodysplastic syndrome (implicated_via_orthology)	TET2 CREBBP	5.87e-04	15	71	2	DOID:0050908 (implicated_via_orthology)
Disease	triglycerides in very small VLDL measurement	BPTF SUGP1 AFF1	5.98e-04	68	71	3	EFO_0022144
Disease	Prostatic Neoplasms	TET2 BAZ2A ARID2 WASF3 CIZ1 LRP2 CREBBP	6.99e-04	616	71	7	C0033578
Disease	Malignant neoplasm of prostate	TET2 BAZ2A ARID2 WASF3 CIZ1 LRP2 CREBBP	6.99e-04	616	71	7	C0376358
Disease	acute myeloid leukemia (is_implicated_in)	TET2 NUP214 CREBBP	1.11e-03	84	71	3	DOID:9119 (is_implicated_in)
Disease	red blood cell density measurement	TET2 SP4 HIVEP1 PTPRF EP400 ARID2 AFF1 RFX7	1.23e-03	880	71	8	EFO_0007978
Disease	PR interval	ARID2 OBSCN NAV2 AFF1 TSC22D2 CTNND2	1.23e-03	495	71	6	EFO_0004462
Disease	health study participation	TET2 FAM120A PTPRF TNRC6A	1.27e-03	195	71	4	EFO_0010130
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	BPTF SUGP1 AFF1 TSC22D2	1.56e-03	206	71	4	EFO_0004612, EFO_0020947
Disease	grip strength measurement	BPTF ZBTB21 TNRC6A ZMYM2 CREB5	1.57e-03	350	71	5	EFO_0006941
Disease	cognitive function measurement, self reported educational attainment	SP4 FAM120A PTPRF TNRC6A QRICH1	1.67e-03	355	71	5	EFO_0004784, EFO_0008354
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	BPTF SP4 SUGP1 AFF1	1.82e-03	215	71	4	EFO_0008317, EFO_0008591
Disease	Sezary Syndrome	TET2 CREBBP	1.93e-03	27	71	2	C0036920
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	BPTF SUGP1 AFF1 TSC22D2	2.11e-03	224	71	4	EFO_0004530, EFO_0008317
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	BPTF SP4 SUGP1 AFF1	2.11e-03	224	71	4	EFO_0004574, EFO_0008317
Disease	cognitive function measurement	SP4 HIVEP1 FAM120A PTPRF PRRC2C TNRC6A POM121L2 LRRC7 TSC22D2 CTNND2	2.21e-03	1434	71	10	EFO_0008354
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	BPTF SP4 SUGP1 AFF1	2.29e-03	229	71	4	EFO_0004639, EFO_0008317
Disease	Epileptic encephalopathy	CACNA1A NUP214	2.38e-03	30	71	2	C0543888
Disease	risk-taking behaviour	TET2 BPTF HIVEP1 PTPRF TNRC6A POM121L2 PHF21A	2.40e-03	764	71	7	EFO_0008579

Protein segments in the cluster

Peptide	Gene	Start	Entry
TVVQVNKNANPDPLP	CACNA1A	1181	O00555
EAQTQLQIPVKTQQP	EP400	621	Q96L91
AQSAPPQPTAQVQVQ	EP400	2836	Q96L91
PQPTAQVQVQTSQPP	EP400	2841	Q96L91
QVQVQTSQPPQQQSP	EP400	2846	Q96L91
PAIQAPVRQQPKVQT	AAK1	591	Q2M2I8
QNQSQTQPLLKTPPA	CCAR1	211	Q8IX12
QPFQAQPPQQKAAVL	BAZ2A	961	Q9UIF9
LVQETNKQPPQTVNP	ATF4	126	P18848
QKQQHPPTYVQNVVP	ARID2	1576	Q68CP9
PTPQVPQVQQSQPSQ	CCNK	281	O75909
PTVQAAAQAQVTPQP	CREBBP	916	Q92793
AAQAQVTPQPQTPVQ	CREBBP	921	Q92793
QPQTQPQSPAQPEVQ	BPTF	2406	Q12830
VPPVNEPETLKQQNQ	CAPRIN1	526	Q14444
KHNQVSAQPVPQEPS	CTNND2	1136	Q9UQB3
NTSPKVAVVNPQPQQ	RAPH1	1096	Q70E73
TPPPQQQQQQLQVTC	QRICH1	431	Q2TAL8
QKFNLPTPPTVENQQ	GUCY2C	1006	P25092
NSPQLKVAQAQPVDP	AFMID	221	Q63HM1
NGVPQQIPKAVPNTE	PARD6B	301	Q9BYG5
ATQQMQPTQTIQPPQ	CREB5	346	Q02930
PASPVPACSQQQVIQ	CREB5	461	Q02930
QQLQQPASQPSPKEA	MAP10	216	Q9P2G4
QSKVVNNSPQPQNVV	ITIH2	91	P19823
TNITPTQKLPTPVNQ	ZBTB33	241	Q86T24
NKVTIQQFQSPLPIQ	LRRC7	1401	Q96NW7
QVTVIVQPENNKPPQ	KIAA0319L	586	Q8IZA0
QPPVQPQVQQQQTAV	MED15	356	Q96RN5
QEQPDKFQIQPLPQS	PHF21A	66	Q96BD5
QVVNVQELKNNPATP	NUP214	1121	P35658
PQSPNLQNPTVTLQK	EXPH5	641	Q8NEV8
KQVQPRSPAEVNNNP	LRP2	2331	P98164
NIPQTSLQAKPVAPQ	FAM120A	366	Q9NZB2
NNVGPISQQPQKSAT	DRC1	441	Q96MC2
AQPQQGQTTPVTMQV	NFYC	181	Q13952
PSVKPQQQQEPLAAV	OBSCN	4841	Q5VST9
AGQVPVTLQPQTQVK	ERVK-19	186	Q9YNA8
AGQVPVTLQPQTQVK	ERVK-21	186	P62683
AGQVPVTLQPQTQVK	ERVK-5	186	Q9HDB9
VQSPVFPPAQKQIHQ	BLNK	291	Q8WV28
VVGQPQPKTSQQPLQ	MAK	331	P20794
SKPVNQNPVIINPTS	MBD5	366	Q9P267
IQGQVQAVKQSLPPT	ESCO1	141	Q5FWF5
QQVAQPSPVSHQQQP	EMSY	421	Q7Z589
TTQQLPKLQQAPNQP	EMSY	1051	Q7Z589
PTIQVKTQQGVPAQP	PTPRF	501	P10586
PKQQAQEAAVPSPQS	MROH5	926	Q6ZUA9
QPQQQIIQAIPPQSF	SP4	411	Q02446
SQQQAVIAQPPQPTQ	TSC22D2	756	O75157
QPSQYSPKQQQIPQS	TAB3	276	Q8N5C8
QAGTPQQQVPVTPQA	NAV2	221	Q8IVL1
QQQGVLPQTVPSQPS	PRRC2C	691	Q9Y520
LVEGKSQIQTPNPNQ	SEMG2	501	Q02383
ANIPTAVQQPSTQVP	TSC22D1	736	Q15714
NSIGNHPQVQKITPN	STARD9	2136	Q9P2P6
QQNQKIPQLPSSPEN	POM121L2	316	Q96KW2
QKQTFTPPPQLQQQQ	SPRR3	6	Q9UBC9
QKSPAQQEPPQRQTV	AFF1	586	P51825
QQEPPQRQTVGTKQP	AFF1	591	P51825
PQKQVQPQVQPQAHS	CIZ1	371	Q9ULV3
KQVQPQVQPQAHSQP	CIZ1	401	Q9ULV3
QVQPQAHSQPPRQVQ	CIZ1	406	Q9ULV3
EQKAKQNQVASPQPP	SUGP1	51	Q8IWZ8
QQPQAQPAQTQAPLV	GTF2A1	256	P52655
KQNPVVEQNSQPPSG	TRIM24	436	O15164
SQQQEKPASFPVPVN	TEX13D	666	A0A0J9YY54
PQSQPEPNKVNHIVT	ZBTB21	826	Q9ULJ3
QQQQQEPVVKTPPAG	RORC	126	P51449
LPTVPQKPSQNFQIQ	SP2	331	Q02086
QGTNQIQKNTPSPDV	SUGP2	266	Q8IX01
VQDQQVVSKNSIPNP	WASF3	106	Q9UPY6
AQQVTQQFVPPTQSK	YAF2	61	Q8IY57
QSVKQAPKTPQNVPA	RFX7	306	Q2KHR2
QPVNAAVAQSPQTIP	YY1AP1	621	Q9H869
PKQIFQPSVQQQPTK	ZMYM2	311	Q9UBW7
QPSVQQQPTKPVKVT	ZMYM2	316	Q9UBW7
KPQVQLHVQSQTQPV	ZYX	231	Q15942
GPTQINQVVSHPNQP	STRN4	636	Q9NRL3
VMQQSQQPQPLQKQP	TET2	1521	Q6N021
PPTSSNIVQGQIKQV	WDR7	936	Q9Y4E6
PDPQEQKQQITLQPT	HIVEP1	2356	P15822
DPNLLVKQQTPPSQQ	TNRC6A	1461	Q8NDV7
VKQQTPPSQQQPLHQ	TNRC6A	1466	Q8NDV7
PQIKPVSQPVGAEQQ	WNK3	676	Q9BYP7